ACUTA CAPITAL PARTNERS, LLC
REDWOOD CITY, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$129.6M2026 Q3+ $2.0M options (notional, not included)
Positions35
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.67.9%
What Changed This Quarter?
Top Holdings
PRAX
Praxis Precision Medicines
18.6%
WHWK
Whitehawk Therapeutics
13.4%
TNGX
Tango Therapeutics
7.8%
FDMT
4D Molecular Therapeutics
5.8%
ARGX
Argenx
4.0%
AVBP
ArriVent BioPharma
3.9%
SRZN
Surrozen
3.7%
VOGX
Vogenx
3.7%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.